Efficacy of Adalimumab Therapy in Patients with Crohn's Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center

被引：1
|
作者：
Shafran, Ira [1 ]
Cangemi, David [1 ]
Burgunder, Patricia [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01212
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1212
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of infliximab therapy in HIV patients with Crohn's disease
    Tessnow, K
    Chiao, L
    Jamjian, C
    Ries, K
    GASTROENTEROLOGY, 2002, 122 (04) : A616 - A616
  • [32] Response after 12 weeks of adalimumab therapy in patients with Crohn's disease who were nonresponders at week 4
    Panaccione, Remo
    Sandborn, William
    Colombel, Jean Fred
    Pollack, Paul
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S379 - S379
  • [33] Impact of Adalimumab therapy after 12 Weeks in patients with Crohn's Disease who were nonresponders at week 4
    Panaccione, R.
    Sandborn, W.
    Colombel, J.
    Pollack, P.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S28 - S28
  • [34] The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre
    Teriaky, Anouar
    Gregor, James
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    Mosli, Mahmoud
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (03) : 280 - 286
  • [35] Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study
    Orlando, Ambrogio
    Renna, Sara
    Mocciaro, Filippo
    Cappello, Maria
    Giunta, Marco
    Mendolaro, Marco
    Mazza, Marta
    Rizzuto, Giulia
    Orlando, Emanuele
    Affronti, Marco
    Dimarco, Mariangela
    Di Mitri, Roberto
    Craxi, Antonio
    Cottone, Mario
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (11) : 1314 - 1317
  • [36] Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients
    Gionchetti, Paolo
    Rizzello, Fernando
    Tambasco, Rosy
    Straforini, Giulia
    Brugnera, Ramona
    Calabrese, Carlo
    Poggioli, Gilberto
    Laureti, Silvio
    Campieri, Massimo
    GASTROENTEROLOGY, 2010, 138 (05) : S328 - S328
  • [37] Clinical experience with infliximab therapy in the initial 256 infusions in patients with Crohn's disease at the Crohn's and Colitis Center of New Jersey
    Glazier, KD
    Shirodkar, MA
    Kosa, E
    Mirza, ZK
    Griffel, LH
    Das, KM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S262 - S262
  • [38] Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
    Echarri, Ana
    Castro, Javier
    Barreiro, Manuel
    Carpio, Daniel
    Pereira, Santos
    Lorenzo, Aurelio
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (06): : 654 - 660
  • [39] Side-Effects to Adalimumab - Single Center Real Life Experience in 111 Crohn's Disease Patients
    Zelinkova, Zuzana
    West, Rachel L.
    Bultman, Evelien
    van Liere-Baron, Astrid
    Mensink, Peter
    van der Woude, Christien J.
    GASTROENTEROLOGY, 2010, 138 (05) : S674 - S674
  • [40] Outcome of infliximab therapy in pediatric Crohn's disease: The first three years experience
    Sant'Anna, AMGA
    Gervais, F
    Deslandres, C
    Seidman, EG
    GASTROENTEROLOGY, 2004, 126 (04) : A458 - A459
12345